Randomized mutagenesis at an endogenous chromosomal locus is a promising approach for protein engineering, functional assessment of regulatory elements, and modeling genetic variations. In mammalian cells, however, it is challenging to perform site-specific single-nucleotide substitution with single-stranded oligodeoxynucleotide (ssODN) donor templates due to insufficient homologous recombination and the infeasibility of positive selection. Here, we developed a DNA transposon based CRISPR-Cas9 regulated transcription and nuclear shuttling (CRONUS) system that enables the stable transduction of CRISPR-Cas9/sgRNA in broad cell types, but avoids undesired genome cleavage in the absence two chemical inducing molecules. Highly efficient single nucleotide alterations induced randomization of desired codons (up to 4 codons) at a defined genomic locus in various human cell lines, including human iPS cells. Thus, CRONUS provides a novel platform for modeling diseases and genetic variations.
nucleotide substitution is a preferred technique for single nucleotide substitutions, but drug-selection cannot be utilized due to the synthesis limit of the donor template (typically a few hundred bases). Hence, it is necessary to perform extensive screening of subclones 10 , or sib-selection methods using droplet digital PCR 11 to enrich rare populations. To enhance HR frequency, the optimization of ssODN donor design 12, 13 , chemical modification of ssODN 14 , or chemical inhibitors [15] [16] [17] (see also Supplementary Table 1) have also been reported. Improved HR efficiency by ssODN donor templates has also been demonstrated in ES/iPS cells using efficient and conditional genome editing systems based on the inducible expression of Cas9 (iCRISPR) [18] [19] [20] . However, establishing the iCRISPR system initially requires a full round of genome editing to introduce the Dox-inducible Cas9 cassette into a safe harbor (i.e. AAVS1) locus. This step is time-consuming and laborious, making it difficult for novices to apply this strategy to a variety of cultured cell lines.
Here, we report an improved piggyBac DNA transposon vector to simplify the establishment of cells which stably express regulatable Cas9 for highly efficient and conditional genome editing. To avoid undesired background cleavage, methods to control Cas9 activity using 4-HT inducible inteins 21 , rapamycin inducible dimerization 22 , or blue-light inducible photoactivation 23 have been employed. In our system, Cas9 is temporally regulated by a doxycycline-inducible TetO promoter [18] [19] [20] 24 in combination with spatial regulation by a steroid hormone receptor for nuclear shuttling 25 to minimize background cleavage. By utilizing our CRONUS (CRISPR-Cas9 regulated by transcription and nuclear-shuttling) system and an appropriate ssODN template, we show highly efficient single nucleotide editing in human cells, including iPS cells. Owing to a very high nucleotide substitution rate via HR, we further demonstrate codon shuffling at the DMD gene locus, which is associated with Duchenne muscular dystrophy 26 , and the HLA-A gene locus, which is a well-known gene that shows large genetic variations between individuals.
Results
piggyBac delivery of dual regulated CRISPR-Cas9 system. We first sought to enhance the genome editing efficiency in human cells by stably expressing the CRISPR-Cas9 transgene into target cells, which avoids suboptimal transduction. At the same time, Cas9 DNA cleavage activity should be regulated to avoid undesired mutagenesis. To develop a regulatable Cas9 expressing vector, we first tested several piggyBac vector constructs in 293T cells by transient transfection. We chose the piggyBac transposon vector because it can efficiently integrate into the genome in various cell types, with a much larger packaging capacity compared with other integrating vectors, such as retroviral/lentiviral vectors. We initially constructed a doxycycline (Dox)-inducible Cas9-expressing piggyBac vector similar what has been recently reported 24 and investigated the genome editing efficiency at exon 45 of the human DMD gene by a luciferase-based single strand annealing (SSA) assay in 293T cells (Fig. 1a) . We observed dose dependent Dox-inducible activity of the Cas9-mediated target cleavage, however, small but considerable background cleavage activity was observed even without Dox. We suspect this is due to leakiness of the TetO promoter, as we utilized regular fetal bovine serum which normally contains a low level of tetracycline. Next, we fused a variant of estrogen receptor (ERT2) 27 or glucocorticoid receptor (GR) with Cas9 to investigate ligand dependent nuclear shuttling of Cas9 upon binding with Z-4-hydroxytamoxifen (4-OHT) or dexamethasone (Dex), respectively. We observed substrate-dependent activation of the Cas9 cleavage activity with GR-Dex, however, the background cleavage activity was significantly higher than those of negative controls (Fig. 1b) .
Because neither the Dox-nor Dex-inducible vector alone showed high background cleavage even in the absence of chemical ligands, we combined both elements into one vector to minimize this background activity (Fig. 1c) . As a result, the background level using the new combined vector was dramatically reduced to a level similar to those of the negative controls, but the cleavage activity could be rapidly induced upon the addition of both Dox and Dex (Fig. 1d) . Although high background cleavage was observed even in the absence of Dox/Dex (0 hour) in vectors regulated by GR-Dex (EF1α-Cas9-GR) or TetO-Dox (TetO-Cas9-NLS), our dual regulated system (TetO-Cas9-GR) showed a reduced background level similar to that of the control without Cas9 (Fig. 1d) . Importantly, from 8 to 24 hours, a sharp induction of Cas9 cleavage activity was observed with the TetO-Cas9-GR dual regulated piggyBac vector, demonstrating efficient induction by combining the two regulatory components. We named our piggyBac vector CRONUS (CRISPR-Cas9 regulated by transcription and nuclear-shuttling).
To test the utility of the CRONUS system for non-homologous end joining (NHEJ) mediated insertion or deletion (indel) induction in human iPS cells, we introduced CRONUS together with a sgRNA-expressing piggyBac vector. Stable integration of the Cas9 and sgRNA vectors was carried out with puromycin and hygromycin, respectively (Fig. 2) . Then, we monitored genome editing efficiency after Dox/Dex treatment by T7EI assay (Fig. 1e) . Genome cleavage was detectable 6 hours after Dox/Dex treatment and reached a plateau by 24 hours. NHEJ mediated genome cleavage activity was over 40% at the DMD gene locus, which is similar to the previously reported iCRISPR system (24-57% for single sgRNA at various gene loci) that expresses Cas9 from the AAVS1 locus 18 .
Enhancement of ssODN-mediated single nucleotide alteration. To functionally assess the impact of single nucleotide variations (SNVs), ssODN-mediated knock-in is a powerful tool, however, the frequency of HR events in human cells is low and screening a large number of subclones is a major bottleneck. To optimize ssODN-mediated targeting, we first developed a sensitive screening method by using two sets of primers specific for detecting modified and non-modified alleles, respectively, to quantify the allele frequency by qPCR (Fig. S1a) Although the allele-specific PCR method can not distinguish whether the allele is perfectly targeted or includes additional indels, it is much quicker than conventional subcloning and sequencing assays. Also, we confirmed that, with our primer design, we could sensitively and quantitatively detect the copy number of the targeted allele as low as 0.1% compared with the non-edited allele (Fig. S1b) . By using this assay system, we first tested transient transfection of Cas9 and sgRNA (targeting the DMD gene) expressing plasmid DNAs in combination with suppression of the NHEJ pathway by siRNAs (targeting KU70, KU80, or LIG4) 16 ( Fig. S1c,d ), but in our hands, no obvious enhancement was detected, partially due to cellular damage of repeated transfections to first deliver siRNA and, later, the plasmid DNA. Next, we tried chemical compounds such as L755507 and Brefeldin A, since they have been reported to enhance the rate of HDR 15 . We also tested YM155, which is a survivin suppressor and known to induce the DNA damage response pathway. However, no obvious enhancement was detected (Fig. S1e) . Since we could induce an extremely high level of NHEJ by using CRONUS in iPS cells, we reasoned that CRONUS would also enhance the efficiency of ssODN-mediated HRs. To this end, we transfected an ssODN template into a male iPS cell line (containing a single copy of the DMD gene) using 4D-Nucleofector (Fig. 3a) in the presence or absence of Dox and Dex and then quantified the genomic copy number of modified DMD gene alleles by qPCR. To our surprise, a very high frequency of knock-in events was observed upon Dox/Dex treatment, which was clearly dependent on the amount of ssODN transfected (Fig. 3b) . We further validated the knock-in by an RFLP assay using the restriction enzyme AgeI, which only cleaves when ssODN-mediated targeting is successful and retains the 6-bp target sequence intact. Approximately 19.7% of the PCR product was successfully cleaved by AgeI, clearly demonstrating the successful knock-in of the ssODN donor (Fig. 3c) . Finally, we assessed the frequency of knock-in by Sanger sequencing of the subclones and found that 47.2% (34/72) of the sequence reads showed random indels, which were presumably generated by NHEJ, whereas 13.9% (10/72) of the clones showed successful knock-in without any indels ( We further targeted additional gene loci, ILF3 on chromosome 19, which is a double-stranded RNA binding protein associated with ovarian cancer, and we observed about 14% of knock-in events in the ILF3 gene (Fig. 4a,b) . In addition, we tested whether the CRONUS system can be used to target an allele-specific sequence by targeting one allele of the HLA-A gene on chromosome 6, which is one of the best examples of genetic variation among individuals. We designed a sgRNA which targets the HLA-A*02:07 sequence, but differs by two nucleotides from the other allele of the HLA-A*32:01 sequence (Fig. S5c) . With this locus, we observed even higher knock-in events (over 30%) when analyzed by the RFLP assay using AvrII restriction enzyme (Fig. 4c) , and we validated the allele specific targeting by utilizing allele-specific PCR amplification and sequencing of the subclones (Fig. 4e,f) .
To test the functional pluripotency of the iPS cells harboring a CRONUS piggyBac vector, we performed embryoid body (EB) differentiation of the original 1383D2 iPS cells and CRONUS-1383D2 iPS cells and monitored the expression levels of the pluripotent marker gene NANOG. As expected, NANOG expression was rapidly down-regulated after 10 days of EB differentiation (Fig. S2b) .
By taking advantage of our inducible Cas9 system, we assessed the time window of Cas9 induction relative to the electroporation timing of ssODN ( A high level of Cas9/sgRNA expression and indel events prompted us to investigate the risk of off-target mutagenesis within the human genome for DMD sgRNA (Fig. S3a), ILF3 sgRNA (Fig. S4a) , and HLA-A sgRNA (Fig. S5a) . Among potential off-target sites predicted by the CRISPOR web tool using the CFD off-target score 28 , mutagenesis was undetectable by the T7EI assay under Dox and Dex treatment (Figs S3b, S4b and S5b,c). Additionally, no background genome cleavage was observed at the on-target site even after several passages in the absence of Dox and Dex treatments (Fig. S3c) , suggesting that high specificity and tight regulation of the CRISPR-Cas9 system is maintained in our CRONUS system. Shuffling of codon sequences at a defined genomic locus. Taking advantage of CRONUS to induce a high frequency of ssODN-mediated HR, we sought to induce site-directed codon shuffling in human iPS cells. We electroporated CRONUS iPS cells with randomized ssODNs at two nucleotide positions on the DMD gene locus to shuffle a codon sequence (from "CTC" to "NNC") without generating a stop codon (Fig. 5a ). Among the 151 subclones analyzed, 53 clones (53/151 = 35.1%) showed expected randomization at the defined two nucleotides without additional indels ( Fig. 5b and Fig. S6 ). This resulted in the generation of all the possible 16 codon sequences (Fig. 5c) . Interestingly, no bias was observed between single nucleotide alterations ("CTC" to "CNC" or "NTC", 24 clones) vs. two nucleotide alterations ("NNC", 29 clones) (Fig. 5d) . Moreover, we also introduced the same approach on the HLA-A gene locus and again found a similar or even greater level of knock-in events, in which 67 clones had been successfully randomized out of 152 clones analyzed (67/152 = 44.1% success rate) (Fig. 6a-d and Fig. S7) .
To test the applicability of the CRONUS system in other human cell lines, we introduced the CRONUS piggyBac vectors into 404C2 iPS cells, HEK293T cells and HeLa cells (Fig. 6e-g ). Even though the same sgRNA targeting the DMD locus was used, we found that the targeting efficiency varied between different cell lines, suggesting different chromatin status and/or DNA repair activity might play a role in modulating the targeting events. Nonetheless, our data demonstrate that the CRONUS piggyBac vector system can be applicable for various cell types to induce a high degree of nucleic acid shuffling at a desired locus.
Lastly, we investigated the number of bases that can be shuffled simultaneously with our CRONUS system. For this experiment, we designed five ssODNs with multiple shuffling sites, up to 8 bases (4 codons) around the Cas9 cleavage site (Fig. 7a) . After electroporation of each ssODN, bulk collected cells were analyzed by amplicon deep sequencing. Interestingly, administration of Dox and Dex induced greater than 60% indels in the absence of ssODN template, whereas some indel events were substituted by base replacement when a ssODN-AgeI or ssODN-NN donor was supplied. The base substitution (randomized) rate was highest with ssODN-AgeI and ssODN-NN1, and was gradually decreased inversely with the number of the randomized bases in the ssODN donor (Fig. 7b) . Although the randomized rate was lowest with the ssODN-NN5 donor template, we confirmed that all 8 bases designed as "N" were successfully incorporated into the genomic sequence we analyzed (Fig. 7c) . Therefore, up to 4 codon sites can be simultaneously randomized by the CRONUS system.
Discussion
In summary, we developed a novel genome editing platform that we termed CRONUS, which utilizes a piggyBac transposon vector for the stable integration of a dual regulated CRISPR-Cas9 system into genomes. CRONUS enables the simple, cost-effective and rapid establishment of cell lines in which highly efficient genome editing can be performed upon the simple addition of two chemical compounds into culture media. By eliminating the need to supply Cas9 and sgRNA exogenously, an extremely high degree of single nucleotide alterations (>10% knock-in events) can be achieved using ssODN donor templates without the need for drug selection. This feature is important in a practical sense because a knock-in frequency greater than 10% indicates that only 10 cell clones would need to be screened to isolate one positive clone versus screening several hundred clones if the knock-in frequency were less than 1%. We anticipate that highly efficient nucleotide alteration might be possible with other inducible Cas9 systems integrated into a safe harbor, such as the iCRISPR system, but our CRONUS piggyBac system does not require the initial targeting and subcloning process to establish the stable cell line, hence it would facilitate the use of genome editing for researchers who are novices in the field.
Interestingly, despite nearly 100% of the cells expressing both Cas9 and sgRNA at a high-level, genome editing efficiency did not reach greater than 50% when measured by the T7EI assay. Of note, prolonged induction of Cas9 for up to 48 hours did not increase the genome editing rate (Fig. 1e) , suggesting the system already reached a saturation point, which is similar to the previously reported Dox-inducible Cas9 system (i.e. iCRISPR). One possible explanation might be that the host DNA repair pathway is actively correcting the sequence precisely after DNA cleavage. However, the reason for the incomplete genome editing is yet to be explored.
We further demonstrated that our CRONUS system enables site-specific random mutagenesis in endogenous human genomes. This feature too has several advantages over traditional in vitro enzymatic or chemical approaches 29 , because the influence of the mutagenesis can be readily detected in the native genomic environment. The current standard in genome editing typically involves the introduction of a single nucleotide substitution one at a time after extensive screening, whereas our method can generate multiple lines with different sequences simultaneously, including the original cell line as an isogenic control. Hence, our approach would facilitate the interrogation of the functional significance of SNVs identified by genome-wide association studies, including tri-allelic SNPs 30 . Furthermore, if the same approach is applied to a protein coding sequence, one could shuffle amino acid sequences at a defined locus for saturation mutagenesis. Thus, our approach would offer an unprecedented methodology for engineering endogenously expressed human proteins to alter functionality, stability and to understand molecular mechanisms in various cell types. Alternatively, nucleic acid sequence could be shuffled without altering the amino acid sequence (i.e. silent mutation) to assess the impact of nonsense mutations 31, 32 . Due to the complexity of bi-allelic targeting, we propose to target a haploid gene (such as the DMD gene on the X chromosome in male cells or HLA-A gene utilizing allele specific SNVs) or to employ "gain-of-function" screening where single allelic targeting would gain a cellular phenotype for subsequent selection and sequencing to identify the corresponding allelic sequences. Given the expanding demand for genome editing, we anticipate that our simple and cost-effective method will help to further model human genetic variations in culture by a broad range of scientists to understand human genetic traits and diseases.
Methods
Vector information. The details of the vector construction procedures are described in the Supplemental Methods section. The vectors and sequence information described in this study will be available on Addgene. Accession codes are: pPV-TetO-SphcCas9-GR-iC-A-EF1α-rtTA-iP (CRONUS-Puro, Addgene ID 100596), pPVTetO-SphcCas9-GR-iC-A-EF1α-rtTA-iH (CRONUS-Hygro, Addgene ID 100597), pPV-H1-ccdB-mEF1α-RiH (piggyBac vector for sgRNA cloning, Addgene ID 100598), and pHL-EF1α-hcPBase-A (piggyBac transposase expression plasmid, Addgene ID 100599). No. 781661-94-7, Calbiochem) was used. These drugs were added to the medium on the same day as Cas9/sgRNA plasmids and ssODN transfection as previously described 15 . We monitored the transfection efficiency by checking the mRFP expression from the pPV-H1-sgRNA-mEF1α-RiH vector and approximately 80% of the cells were RFP positive. Two days after plasmid and ssODN transfection, cells reached near confluency and were harvested for genotyping. It is worth noting that the cells treated with 10 μM of YM155 showed marked cellular toxicity by visual inspection using an inverted microscope.
To establish CRONUS iPS cell lines, 1 × 10 6 cells were suspended in 100 μL of Opti-MEM I (Cat. No. 31985-070, Thermo Fisher Scientific) with piggyBac vectors (pPV-TetO-SphcCas9-iC-A-EF1α-rtTA-iP: 4 μg, pPV-H1-gRNA-mEF1α-RiH: 4 μg) and a piggyBac transpose vector (pHL-EF1α-hcPBase-A: 2 μg). Cells were then electroporated with a NEPA 21 electroporator (poring pulse: pulse voltage, 125 V; pulse width, 5 ms; pulse number, 2; Nepa Gene) in a 0. (20-25 °C) . Then, tripsinized 293T cells were added to each well at 50,000 cells/100 μL/well. On the next day of transfection, we measured firefly and renilla luciferase activity by using Dual-Glo Luciferase Assay Kit (Cat. No. E2920, Promega) and LAS-3000 imaging system (Fujifilm). Firefly luciferase activity was normalized by renilla luciferase value and used as a readout of the target cleavage by Cas9 and corresponding gRNA.
Assessment of genome editing efficiency by T7EI assay. The CRISPR-sgRNA target site was amplified by a high-fidelity PCR reaction from genomic DNA and purified by Wizard SV Gel and the PCR Clean up System (Promega). The primer sequences for PCR are shown in Supplementary Table 5 . Purified PCR products (400 ng) were denatured (95 °C for 5 min) and re-annealed by gradually cooling from 95 °C to 85 °C at −2 °C/ sec and 85 °C to 25 °C at −0.1 °C/sec in NEBuffer 2 (NEB) using a programmable thermocycler. The re-annealed PCR product was digested by 10 units of T7 endonuclease I (T7EI, NEB, Cat. No. M0302L) for 15 minutes at 37 °C. The reaction was stopped by the addition of 0.25 M EDTA solution, and the sample was placed on ice. The PCR products were analyzed on 2% agarose gel to quantify the intensity of the digested and undigested bands by ImageJ software or on High Sensitivity D1000 ScreenTape with TapeStation 2200 (Agilent Technologies). The percentage of nuclease-specific cleavage peak area in the summed band area (expressed as the fraction cleaved) was used to estimate the gene editing levels using the following equation 35 , % mutation = 100 Supplementary Table 6 . After electroporation, cells were transferred to 1.2 μg/well iMatrix-511-coated 12-well plates and grown in AK03N medium containing ROCK inhibitor Y-27632. To perform genome cleavage, 2 μM Dox and 1 μM Dex were added into the medium, and cells were cultured for 24-48 hours.
To check knock-in efficiency, genomic DNA was extracted from the transfected cells and analyzed by qPCR, RFLP and Sanger sequencing. qPCR was performed with specific primers according to the manufacturer's instructions. The primer sequences for qPCR are shown in Supplementary Table 7 .
The genomic regions around the sgRNA target site for the DMD, ILF3, and HLA-A genes were amplified by PCR. The sgRNA target sequences are shown in Supplementary Table 2. To check whether the designed restriction sites (AgeI, PstI or AvrII) were introduced via ssODN-mediated knock-in experiments, the PCR product was digested with the indicated restriction enzyme and analyzed by agarose gel electrophoresis or 2200 TapeStation (Agilent Technologies). The primer sequences for PCR are shown in Supplementary Table 5 .
To determine the frequency of indel and HR, PCR products were cloned with TA-cloning. Picked colonies were boiled in water, used as templates for PCR amplification and enzymatically cleaned up by Exonuclease I (Cat. No. 2650 A, Takara) and Alkaline phosphatase (Shrimp) (Cat. No. 2660 A, Takara). The sequences of each clone were analyzed by using a BigDye Terminator v3.1 Cycle Sequencing Kit (Cat. No. 4337455, Thermo Fisher) and Applied Biosystems 3500xL Genetic Analyzers. Low quality sequence reads (i.e. no signal or mixed signals) were discarded, and the remaining multiple FASTA sequence files were combined by Unix "cat" command and aligned by "clustalo" algorithm using SeaView software. The logos of DNA and protein sequences were generated by WebLogo software (http://weblogo.threeplusone.com/create.cgi).
We isolated iPS cell subclones as previously described 36 . Briefly, ssODN-transfected iPS cells were treated with Y-27632 treatment for at least one hour and dissociated into single cells by TrypLE. Counted cells were plated at the density of 100-1,000 cells per one well of 6-well plate coated with iMatrix-511. Individual colonies were manually picked under EVOS FL microscope (Thermo Fisher) within a clean cabinet and genotyped by genomic PCR using the primers shown in Supplementary Table 5 .
Analysis of randomization patterns by Amplicon sequencing. The target region was PCR amplified with barcoding primers (DMD-MiSeq-Rd1-fwd1-9 and DMD-MiSeq-Rd2-rev1-9, shown in Supplementary  Table 8 ) and then adapter primers (Multiplex P5 fwd and Multiplex P7 rev, shown in Supplementary Table 8) using a high-fidelity PCR enzyme. The resultant PCR products were gel-purified and quantified by the KAPA Library Quantification Kit for Illumina (Cat. no. KK4835, KAPA Biosystems). Each DNA sample was adjusted to 2 nM and denatured by freshly made 0. the barcode indices by a custom shell script. Perfectly matched reads for the original sequence or ssODN template were separated, and the remaining reads, which include sequencing errors, were considered as indel sequences.
Statistic analysis.
To perform Student's t-test, T.TEST function in Excel software was used with two tailed, non-paired, unequal variance analysis options. p < 0.05 was considered as statistically significant.
Data availability. The datasets generated during the current study are available from the corresponding author on reasonable request.
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